MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.
Oct 14, 2025, 12:03 PM EDT - 11 days ago
Oct 10, 2025, 8:18 AM EDT - 15 days ago
Oct 9, 2025, 3:18 PM EDT - 15 days ago
Oct 8, 2025, 10:15 AM EDT - 17 days ago
Oct 8, 2025, 7:36 AM EDT - 17 days ago
Oct 6, 2025, 8:59 PM EDT - 18 days ago
Oct 6, 2025, 2:35 PM EDT - 18 days ago
Oct 6, 2025, 8:36 AM EDT - 19 days ago
Oct 6, 2025, 6:23 AM EDT - 19 days ago
CRVL HRMY
Oct 5, 2025, 11:43 PM EDT - 19 days ago
Oct 4, 2025, 7:07 AM EDT - 21 days ago
Oct 1, 2025, 3:02 PM EDT - 23 days ago
Sep 29, 2025, 6:20 PM EDT - 25 days ago
Sep 29, 2025, 6:07 PM EDT - 25 days ago
Sep 29, 2025, 2:44 PM EDT - 25 days ago
Sep 29, 2025, 10:53 AM EDT - 26 days ago
Sep 29, 2025, 9:05 AM EDT - 26 days ago
Sep 29, 2025, 9:02 AM EDT - 26 days ago
Sep 29, 2025, 8:06 AM EDT - 26 days ago
IVA
Sep 28, 2025, 12:04 PM EDT - 27 days ago
Aug 27, 2025, 12:50 PM EDT - 2 months ago
ABVX
Aug 5, 2025, 7:00 AM EDT - 2 months ago
Jun 3, 2025, 3:08 PM EDT - 5 months ago
Jun 2, 2025, 5:08 PM EDT - 5 months ago
MRK
May 12, 2025, 4:00 PM EDT - 5 months ago
Apr 25, 2025, 4:05 PM EDT - 6 months ago
Apr 8, 2025, 3:31 AM EDT - 7 months ago
Apr 3, 2025, 7:00 AM EDT - 7 months ago
Feb 26, 2025, 7:00 AM EST - 8 months ago
Jan 17, 2025, 6:03 PM EST - 10 months ago
Jan 8, 2025, 7:00 AM EST - 10 months ago
Sep 9, 2024, 7:00 AM EDT - 1 year ago
Jul 18, 2024, 2:19 PM EDT - 1 year ago
May 16, 2024, 8:00 AM EDT - 1 year ago
May 12, 2024, 8:37 AM EDT - 1 year ago
May 7, 2024, 8:00 AM EDT - 1 year ago
Apr 10, 2024, 7:00 AM EDT - 1 year ago
Mar 10, 2024, 12:00 PM EDT - 1 year ago